- Home
- RMTI vs DYAI Comparison
RMTI vs DYAI Comparison
Compare RMTI & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RMTI | DYAI |
|---|---|---|
| Founded | 1994 | 1979 |
| Country | United States | United States |
| Employees | 157 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.9M | 32.5M |
| IPO Year | 2022 | 2003 |
Fundamental Metrics
Financial Performance| Metric | RMTI | DYAI |
|---|---|---|
| Price | $7.38 | $0.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.00 | ★ $3.00 |
| AVG Volume (30 Days) | 27.7K | ★ 252.2K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $69,258,000.00 | $3,090,345.00 |
| Revenue This Year | $8.64 | $122.79 |
| Revenue Next Year | $8.44 | $100.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.55 | $0.65 |
| 52 Week High | $7.68 | $1.60 |
Technical Indicators
Market Signals| Indicator | RMTI | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 82.59 | 43.16 |
| Support Level | $0.80 | $0.76 |
| Resistance Level | N/A | $1.21 |
| Average True Range (ATR) | 0.45 | 0.16 |
| MACD | -0.08 | -0.04 |
| Stochastic Oscillator | 85.23 | 0.78 |
Price Performance
Historical ComparisonAbout RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
About DYAI Dyadic International Inc.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.